KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Common Equity (2016 - 2025)

Cme (CME) has disclosed Common Equity for 17 consecutive years, with $28.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 8.46% to $28.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $28.7 billion, a 8.46% increase, with the full-year FY2025 number at $28.7 billion, up 8.46% from a year prior.
  • Common Equity was $28.7 billion for Q4 2025 at Cme, up from $28.2 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $28.7 billion in Q4 2025 to a low of -$100.2 million in Q2 2023.
  • A 5-year average of $17.6 billion and a median of $24.5 billion in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: tumbled 216.09% in 2023, then skyrocketed 6621825.0% in 2024.
  • Cme's Common Equity stood at $27.4 billion in 2021, then tumbled by 82.68% to $4.7 billion in 2022, then tumbled by 100.01% to -$400000.0 in 2023, then surged by 6621825.0% to $26.5 billion in 2024, then increased by 8.46% to $28.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Common Equity are $28.7 billion (Q4 2025), $28.2 billion (Q3 2025), and $45.4 million (Q2 2025).